Pilipenko S. V., Beregova T. V., Kabanov A. V., Yankovskiy D. S.

The Influence of Multiprobiotoc «аpibact®» on Colon Motility in the Rats in Conditions of Long-Term Hypoacidty of Gastric Juice

About the author:

Pilipenko S. V., Beregova T. V., Kabanov A. V., Yankovskiy D. S.



Type of article:

Scentific article


The aim of the study was to investigate the influence of multiprobiotic “Apibact®” on changes in colon motility in the rats evoked by long-term injection of omeprazole. The research was conducted on 30 white nonlinear rats (males) weighing 170-200 grams which were divided into 3 groups. Animals of the 1st group (control) during 28 days were injected with H2O: 0,2 ml intraperitoneally (i. p.) and 0,5 ml per os. Animals of the 2nd group during 28 days were treated with omeprazole (Omez®, Sigma-Aldrich, USA) (14 mg/kg, diluted in 0,2 ml of H2O, per os) and 0,5 ml H2O i. p. Animals of the 3rd group during 28 days were simultaneously treated with omeprazole and multiprobiotic “Apibact®” (Limited company “O. D. Prolisok”, Ukraine). Multiprobiotic “Apibact®” is concentrated fluid biomass of bioplasts of symbiosis of 14 probiotic microorganisms strains (cell concentration saccharolytic anaerobes 1012 CFU / dose) and their physiologically valuable metabolites (vitamins, polysaccharides, short chain fatty acids, enzymes, essential amino acids, peptides, etc.). Also Multipro- biotic “Apibact®” contains 2,5 % extract of propolis that increased its anti-inflammatory action. In a day after last introduction of omeprazole, omeprazole ± multiprobiotic or water, an experiment was carried out to determine the spontaneous and stimulated colon motility. Each experiment started in the morning, on an empty stomach, after a day of starvation and free access to water. Animals were anesthetized with urethane (Sigma-Aldrich, USA) in dose 1,1 g/kg (i. p.). Colon motility was investigated by balloon-graphyc method. In a one hour of record of spontaneous contractions the rats were treated with standard stimulant of colon nonselective agonist of acetylcholine receptors carbachol (10 mkg/kg i. p.) and recorded colon motility yet during one hour. The following parameters were calcu- lated motility: the frequency and amplitude of contractions, the index of motor activity. The decrease of gastric secretion by omeprazole during 28 days didn’t influence on frequency of spontaneous contractions in colon but diminished amplitude of contractions by 66,7 % (р < 0,01) and index of motor activity – by 11 (p < 0,05). After 28 days of omeprazole injection colon motility stimulated by carbahol was significantly dimin- ished: amplitude of contractions and the index of motor activity decreased respectively by 80 % (р < 0,001) and 17,7 % (р < 0,05) in comparison with control. After 28 days of coadministration of omeprazole and multiprobiotic “Apibact®” amplitude of spontaneous con- tractions increased by 110 % (p < 0,05) versus a control group of rats treated with omeprazole alone but it remained below control values on 30 % (p < 0,05). The index of motor activity was restored to control values. In rats treated during 28 days with omeprazole and multiprobiotic “Apibact®” colon motor reaction on carbachol was significantly higher versus the rats treated only omeprazole. Amplitude of contractions enhanced by 263,6 % (р < 0,001) also it remained below in comparison with control by 27,3 % (р < 0,05). The index of motor activity enhanced to control level. We concluded: 1) multiprobiotic prevents the development of dysbiosis in colon that maintains normal short- chain fatty acids levels which have an important role in the regulation of motility; 2) multiprobiotics are preventative measures to eliminate the negative effects of long-term of gastric hypoacidity on colon motility.


colon, motility, omeprazole, multiprobiotic


  • Берегова Т. В. Профілактична дія мультипробіотиків групи «Симбітер» на структурно-функціональні зміни в травному тракті, викликані тривалим зниженням секреції соляної кислоти / Т. В. Берегова, Л. І. Остапченко, О. І. Цирюк [та ін.]//
  • Научно-практическая конференция «Биологически активные вещества:фундаментальные и прикладные вопросы получения и применения», Новый Свет, Крым, Украина, 25-30 мая 2009. – С. 225-226.
  • Звягинцева Т. Д. Коррекция моторно-эвакуаторных нарушений кишечника при синдроме раздраженного кишечника с запором / Т. Д. Звягинцева, А. И. Чернобай // Сучасна гастроентерологія. – 2010. – № 3 (53). – С. 87-94.
  • Пилипенко С. В. / С. В. Пилипенко, Т. В. Береговая, Ю. В. Цейслер [и др.] // Моторика толстой кишки в условиях дли- тельного введения омепразола и ее коррекция мультипробиотиком // Биотехнология. – 2014. (в печати).
  • Пчелиный мед / Прополис. Эл. ресурс http://www. beehoney. ru/propolis_sostavbee. html].
  • Радчук О. М. Морфометричні показники слизової оболонки товстої кишки щурів за умов тривалої гіпергастринемії та при введенні мультипробіотика «Симбітер® ацидофільний» і масляної кислоти / О. М. Радчук, О. г. Короткий, О. І. Цирюк // «Біологія: від молекули до біосфери». Матеріали III Міжнародної конференції молодих науковців (18-21 листопада 2008р., м. Харків, Україна). – Харків : СПД ФО Михайлов г. г., 2008. – С. 154-155.
  • Basnet P. Potent free radical scavenging activity of propol isolated from Brazilian propolis / P. Basnet, T. Matsuno, R. Neidlein// Zeitschrift fьr Naturforschung C. – 1997. – Vol. 52, № 11-12. – P. 828–833.
  • Dobrowolski J. W. Antibacterial, antifungal, antiamoebic, antiinflammatory and antipyretic studies on propolis bee products /J. W. Dobrowolski, S. B. Vohora, K. Sharma [et al.]// Journal of Ethnopharmacology. – 1991. – Vol. 35, № 1. – P. 77–82.
  • Fukumoto S. Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats / S. Fukumoto, M. Tatewaki,T. Yamada [et al.]// American Journal of Physiology – Regulatory, Integrative and Comparative Physiology. – 2003. – Vol. 284.– R1269-R1276.
  • Fьlцp K. Characterisation of a-2-adrenoreceptor subtypes involved in gastric emptying, gastric motility and gastric mucosa defence / K. Fьlцp, Z. Zбdori, A. Z. Rбnai, K. Gyires // European Journal of Pharmacology. – 2005. – Vol. 528. – P. 150-157.
  • Kimoto T. Apoptosis of human leukemia cells induced by Artepillin C, an active ingredient of Brazilian propolis / T. Kimoto,M. Aga, K. Hino [et al.] // Anticancer Research // 2001. – Vol. 21, № 1A. – P. 221–228.Kimoto T. Apoptosis and suppression of tumor growth by Artepillin C extracted from Brazilian propolis / T. Kimoto, S. Arai,M. Kohguchi [et al.] // Cancer Detection and Prevention. – 1998. – Vol. 22, № 6. – P. 506–515.
  • Machado J. L. Brazilian Green Propolis: Anti-inflammatory property by an immunomodulatory activity / J. L. Machado, A. K.M. Assunзгo, M. C. P. da Silva [et al.] //Evid Based Complement Alternat Med. – 2012; 2012: 157652. Published online 2012 December 19. doi: 10. 1155/2012/157652.
  • Marcucci M. C. Propolis: chemical composition, biological properties and therapeutic activity / M. C. Marcucci // Apidologie.– 1995. – Vol. 26, № 2. – P. 83–99.
  • Matsuno T. Isolation and characterization of cytotoxic diterpenoid isomers from propolis / T. Matsuno, Y. Matsumoto, M. Saito,J. Morikawa// Zeitschrift fьr Naturforschung C. – 1997. – Vol. 52, № 9-10. – P. 702–704.
  • Park Y. K. Antimicrobial activity of propolis on oral microorganisms / Y. K. Park, M. H. Koo, J. A. S. Abreu [et al.]// Current Microbiology. –1998. – Vol. 36, №1. – P. 24–28.
  • Takeuchi K. Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage / K. Takeuchi, A. Tanaka, R. Ohno, A. Yokota// J. Physiol. Pharmacol. – 2003. – Vol. 54, Suppl. 4. – P. 165-182.
  • Tazoe H. Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions / H. Tazoe, Y. Otomo, I. Kaji [et al.]// J Physiol Pharmacol. – 2008. – Vol. 59, Suppl. 2. – P. 251-262.
  • Vynograd N. A comparative multi-centre study of the efficacy of propolis, acyclovir and placebo in the treatment of genital herpes (HSV) / N. Vynograd, I. Vynograd, Z. Sosnowski // Phytomedicine. – 2000. – Vol. 7, №1. – P. 1–6.

Publication of the article:

«Bulletin of problems biology and medicine» Issue 1 (106), 2014 year, 162-166 pages, index UDK 591. 1 ± 577. 353